Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-Line Sunitinib (QUASAR): Results of a Phase I Trial
C. Buonerba, Pietro De Placido, D. Bruzzese, M. Pagliuca, P. Ungaro, Davide Bosso, Dario Ribera, Simona Iaccarino, Luca Scafuri, Antonietta Liotti, V. Romeo, M. Izzo, F. Perri, Beniamino Casale, G. Grimaldi, F. Vitrone, A. Brunetti, D. Terracciano, A. Marinelli, S. De Placido, G. Di Lorenzo
Frontiers in Pharmacology